.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Colorcon
Julphar
Medtronic
Covington
Farmers Insurance
Mallinckrodt
Johnson and Johnson
Healthtrust

Generated: November 19, 2017

DrugPatentWatch Database Preview

ACITRETIN Drug Profile

« Back to Dashboard

Which patents cover Acitretin, and when can generic versions of Acitretin launch?

Acitretin is a drug marketed by Mylan Pharms Inc, Sigmapharm Labs Llc, Impax Labs Inc, Barr Labs Inc, and Teva Pharms Usa. and is included in six NDAs.

The generic ingredient in ACITRETIN is acitretin. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acitretin profile page.

Pharmacology for ACITRETIN

Ingredient-typeRetinoids
Drug ClassRetinoid

Medical Subject Heading (MeSH) Categories for ACITRETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ACITRETIN
acitretin
CAPSULE;ORAL203707-001Sep 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ACITRETIN
acitretin
CAPSULE;ORAL202148-001Sep 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
ACITRETIN
acitretin
CAPSULE;ORAL204633-002May 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
ACITRETIN
acitretin
CAPSULE;ORAL202552-004Dec 23, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ACITRETIN
acitretin
CAPSULE;ORAL202148-002Sep 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ACITRETIN
acitretin
CAPSULE;ORAL202897-002Apr 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr Labs Inc
ACITRETIN
acitretin
CAPSULE;ORAL091455-002Apr 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
ACITRETIN
acitretin
CAPSULE;ORAL203707-002Sep 10, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
ACITRETIN
acitretin
CAPSULE;ORAL204633-001May 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
ACITRETIN
acitretin
CAPSULE;ORAL204633-004May 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Merck
Cantor Fitzgerald
Covington
Moodys
Healthtrust
Daiichi Sankyo
Mallinckrodt
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot